Pomerantz Roger
Insider CIK 1614936 · VIRX Director · CFRX Chief Executive Officer, Director · MCRB President and CEO, Director · NTEC Director · RUBY Director · INDP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2025-06-10 | 2025-06-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2025-04-10 | 2025-04-11 | 250 | $0.50 | $125 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2025-04-10 | 2025-04-11 | 250 | $0.50 | $125 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2025-04-10 | 2025-04-11 | 500 | $0.50 | $250 | 0 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2024-11-25 | 2024-11-27 | 9,034 | — | $0 | 18,069 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2024-11-25 | 2024-11-27 | 9,034 | — | $0 | 126,478 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2024-08-25 | 2024-09-12 | 9,034 | — | $0 | 27,103 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2024-08-25 | 2024-09-12 | 9,034 | — | $0 | 117,444 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 18,750 | — | $0 | 18,750 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2024-06-06 | 2024-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2024-05-25 | 2024-05-29 | 9,035 | — | $0 | 36,137 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2024-05-25 | 2024-05-29 | 9,035 | — | $0 | 108,410 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2024-02-25 | 2024-02-27 | 9,034 | — | $0 | 45,172 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2024-02-25 | 2024-02-27 | 9,034 | — | $0 | 99,375 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2023-11-25 | 2023-11-28 | 9,034 | — | $0 | 54,206 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2023-11-25 | 2023-11-28 | 9,034 | — | $0 | 90,341 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2023-08-25 | 2023-08-29 | 9,034 | — | $0 | 63,240 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2023-08-25 | 2023-08-29 | 9,034 | — | $0 | 81,307 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2023-08-16 | 2023-08-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2023-05-25 | 2023-05-26 | 9,035 | — | $0 | 72,274 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2023-05-25 | 2023-05-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2023-05-25 | 2023-05-26 | 9,035 | — | $0 | 72,273 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2023-02-25 | 2023-02-28 | 9,034 | — | $0 | 81,309 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2023-02-25 | 2023-02-28 | 9,034 | — | $0 | 63,238 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2022-11-25 | 2022-11-29 | 9,034 | — | $0 | 90,343 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2022-11-25 | 2022-11-29 | 9,034 | — | $0 | 54,204 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2022-09-30 | 2022-10-03 | 81,000 | — | $0 | 81,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2022-08-25 | 2022-08-29 | 9,034 | — | $0 | 99,377 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2022-08-25 | 2022-08-29 | 9,034 | — | $0 | 45,170 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2022-08-10 | 2022-08-11 | 30,282 | — | $0 | 30,282 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2022-05-25 | 2022-05-27 | 9,034 | — | $0 | 108,411 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2022-05-25 | 2022-05-27 | 9,034 | — | $0 | 36,136 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2022-02-25 | 2022-03-01 | 9,034 | — | $0 | 117,445 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2022-02-25 | 2022-03-01 | 9,034 | — | $0 | 27,102 | SEC↗ |
| CFRX CONTRAFECT Corp | A Award deriv | 2022-02-15 | 2022-02-17 | 500,000 | $3.33 | $1.67M | 500,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2021-11-25 | 2021-11-29 | 18,068 | — | $0 | 126,479 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2021-11-25 | 2021-11-29 | 18,068 | — | $0 | 18,068 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2021-08-04 | 2021-08-06 | 41,000 | — | $0 | 41,000 | SEC↗ |
| CFRX CONTRAFECT Corp | A Award deriv | 2021-04-08 | 2021-04-13 | 254,000 | — | $0 | 254,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2021-03-26 | 2021-03-30 | 135,000 | — | $0 | 135,000 | SEC↗ |
| NTEC Intec Pharma Ltd. | A Award deriv | 2020-07-15 | 2020-07-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NTEC Intec Pharma Ltd. | A Award deriv | 2019-06-28 | 2019-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2019-06-13 | 2019-06-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-09-07 | 2018-09-11 | 1,810 | $9.00 | $16.3K | 213,976 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-09-06 | 2018-09-06 | 3,013 | $9.04 | $27.2K | 215,786 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-09-05 | 2018-09-06 | 9,505 | $9.12 | $86.7K | 218,799 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | P Buy | 2018-07-20 | 2018-07-23 | 100 | $23.00 | $2.3K | 100 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2018-07-17 | 2018-07-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2018-07-11 | 2018-07-12 | 1,010 | — | $0 | 797,536 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-07-11 | 2018-07-12 | 1,010 | $9.01 | $9.1K | 228,304 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2018-07-11 | 2018-07-12 | 1,010 | $0.71 | $717 | 229,314 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2018-07-10 | 2018-07-10 | 5,989 | — | $0 | 798,546 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2018-07-10 | 2018-07-10 | 5,989 | $0.71 | $4.3K | 234,293 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-07-10 | 2018-07-10 | 5,989 | $9.05 | $54.2K | 228,304 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2018-07-09 | 2018-07-10 | 10,981 | — | $0 | 804,535 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-07-09 | 2018-07-10 | 10,981 | $9.14 | $100.4K | 228,304 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2018-07-09 | 2018-07-10 | 10,981 | $0.71 | $7.8K | 239,285 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2018-07-06 | 2018-07-10 | 15,366 | — | $0 | 815,516 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2018-07-06 | 2018-07-10 | 15,366 | $0.71 | $10.9K | 243,670 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-07-06 | 2018-07-10 | 15,366 | $9.14 | $140.4K | 228,304 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2018-06-29 | 2018-06-29 | 4,496 | — | $0 | 830,882 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2018-06-29 | 2018-06-29 | 4,496 | $0.71 | $3.2K | 232,800 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-06-29 | 2018-06-29 | 4,496 | $9.10 | $40.9K | 228,304 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2018-06-28 | 2018-06-29 | 21,560 | — | $0 | 835,378 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-06-28 | 2018-06-29 | 21,560 | $9.15 | $197.3K | 228,304 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2018-06-28 | 2018-06-29 | 21,560 | $0.71 | $15.3K | 249,864 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2018-06-27 | 2018-06-27 | 16,991 | — | $0 | 856,938 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2018-06-27 | 2018-06-27 | 16,991 | $0.71 | $12.1K | 245,295 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-06-27 | 2018-06-27 | 16,991 | $9.03 | $153.4K | 228,304 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2018-06-26 | 2018-06-27 | 21,224 | — | $0 | 873,929 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2018-06-26 | 2018-06-27 | 21,224 | $0.71 | $15.1K | 249,528 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-06-26 | 2018-06-27 | 21,224 | $9.19 | $195.0K | 228,304 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2018-06-25 | 2018-06-27 | 16,288 | — | $0 | 895,153 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-06-25 | 2018-06-27 | 26,752 | $9.21 | $246.4K | 228,304 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2018-06-25 | 2018-06-27 | 16,288 | $0.71 | $11.6K | 255,056 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-06-22 | 2018-06-22 | 40,057 | $9.36 | $374.9K | 238,768 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-06-21 | 2018-06-22 | 18,987 | $9.06 | $172.0K | 278,825 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-06-20 | 2018-06-22 | 26,492 | $9.33 | $247.2K | 297,812 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2018-05-09 | 2018-05-10 | 233 | $9.00 | $2.1K | 324,304 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2018-01-30 | 2018-01-30 | 278,000 | — | $0 | 278,000 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2018-01-24 | 2018-01-25 | 40,241 | — | $0 | 911,441 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2018-01-24 | 2018-01-25 | 40,241 | $0.71 | $28.6K | 324,537 | SEC↗ |
| CFRX CONTRAFECT Corp | P Buy deriv | 2017-07-25 | 2017-07-26 | 400 | $0.01 | $4 | 400 | SEC↗ |
| CFRX CONTRAFECT Corp | P Buy | 2017-07-25 | 2017-07-26 | 800 | $1.24 | $992 | 800 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2017-07-18 | 2017-07-20 | 100,604 | — | $0 | 951,682 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2017-07-18 | 2017-07-20 | 100,604 | $0.71 | $71.4K | 284,296 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2017-01-26 | 2017-01-27 | 261,000 | — | $0 | 261,000 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-07-27 | 2016-07-28 | 20,000 | — | $0 | 1,052,286 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-07-27 | 2016-07-28 | 20,000 | $35.00 | $700.0K | 183,692 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-07-27 | 2016-07-28 | 20,000 | $0.71 | $14.2K | 203,692 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-07-06 | 2016-07-07 | 35,435 | — | $0 | 1,072,283 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-07-06 | 2016-07-07 | 35,435 | $0.71 | $25.2K | 219,127 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-07-06 | 2016-07-07 | 9,900 | $29.27 | $289.8K | 209,227 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-07-06 | 2016-07-07 | 25,535 | $29.80 | $760.9K | 183,692 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-07-05 | 2016-07-07 | 52,776 | — | $0 | 1,107,718 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-07-05 | 2016-07-07 | 2,905 | $29.96 | $87.0K | 183,692 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-07-05 | 2016-07-07 | 52,776 | $0.71 | $37.5K | 236,468 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-07-05 | 2016-07-07 | 49,871 | $29.27 | $1.46M | 186,597 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-07-01 | 2016-07-05 | 56,789 | — | $0 | 1,160,497 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-07-01 | 2016-07-05 | 41,957 | $29.84 | $1.25M | 193,692 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-07-01 | 2016-07-05 | 56,789 | $0.71 | $40.3K | 240,481 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-07-01 | 2016-07-05 | 4,832 | $29.12 | $140.7K | 235,649 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-07-01 | 2016-07-05 | 10,000 | $30.00 | $300.0K | 183,692 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-06-02 | 2016-06-06 | 74,049 | — | $0 | 1,217,286 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-06-02 | 2016-06-06 | 74,049 | $0.71 | $52.6K | 257,741 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-06-02 | 2016-06-06 | 47,159 | $32.34 | $1.53M | 203,999 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-06-02 | 2016-06-06 | 20,307 | $33.22 | $674.6K | 183,692 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-06-02 | 2016-06-06 | 6,583 | $31.62 | $208.2K | 251,158 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-06-01 | 2016-06-02 | 70,951 | — | $0 | 1,291,335 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-06-01 | 2016-06-02 | 18,510 | $30.12 | $557.5K | 236,133 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-06-01 | 2016-06-02 | 52,441 | $30.65 | $1.61M | 183,692 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-06-01 | 2016-06-02 | 70,951 | $0.71 | $50.4K | 254,643 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-05-24 | 2016-05-25 | 9,801 | — | $0 | 1,362,286 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-24 | 2016-05-25 | 9,801 | $30.00 | $294.0K | 183,692 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-05-24 | 2016-05-25 | 9,801 | $0.71 | $7.0K | 193,493 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-05-18 | 2016-05-19 | 160,965 | — | $0 | 1,372,087 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-05-18 | 2016-05-19 | 160,965 | $0.71 | $114.3K | 183,692 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-05-06 | 2016-05-09 | 8,507 | — | $0 | 1,533,052 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-06 | 2016-05-09 | 308 | $25.10 | $7.7K | 22,727 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-06 | 2016-05-09 | 8,199 | $24.28 | $199.1K | 23,035 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-05-06 | 2016-05-09 | 8,507 | $0.71 | $6.0K | 31,234 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-05-05 | 2016-05-06 | 30,027 | — | $0 | 1,541,559 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-05-05 | 2016-05-06 | 8,900 | $0.71 | $6.3K | 31,627 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-05-05 | 2016-05-06 | 21,127 | $0.71 | $15.0K | 43,854 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-05 | 2016-05-06 | 21,127 | $25.48 | $538.3K | 22,727 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-05 | 2016-05-06 | 8,900 | $26.34 | $234.4K | 22,727 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-05-04 | 2016-05-06 | 29,298 | — | $0 | 1,571,586 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-04 | 2016-05-06 | 700 | $27.31 | $19.1K | 22,727 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-05-04 | 2016-05-06 | 700 | $0.71 | $497 | 23,427 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-05-04 | 2016-05-06 | 28,598 | $0.71 | $20.3K | 51,325 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-04 | 2016-05-06 | 28,598 | $26.52 | $758.4K | 22,727 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-05-03 | 2016-05-04 | 23,680 | — | $0 | 1,600,884 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-05-03 | 2016-05-04 | 23,680 | $0.71 | $16.8K | 46,407 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-03 | 2016-05-04 | 16,338 | $27.80 | $454.2K | 30,069 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-03 | 2016-05-04 | 200 | $29.32 | $5.9K | 22,727 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-03 | 2016-05-04 | 7,142 | $28.44 | $203.1K | 22,927 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-05-02 | 2016-05-04 | 43,687 | — | $0 | 1,624,564 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-02 | 2016-05-04 | 8,249 | $29.59 | $244.1K | 22,727 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-02 | 2016-05-04 | 35,438 | $28.95 | $1.03M | 30,976 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-05-02 | 2016-05-04 | 43,687 | $0.71 | $31.0K | 66,414 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-04-07 | 2016-04-11 | 7,500 | — | $0 | 1,668,251 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-04-07 | 2016-04-11 | 1,712 | — | $0 | 82,500 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-04-07 | 2016-04-11 | 9,212 | $30.00 | $276.4K | 22,727 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-04-07 | 2016-04-11 | 1,712 | $0.48 | $822 | 24,439 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-04-07 | 2016-04-11 | 7,500 | $0.71 | $5.3K | 31,939 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-04-04 | 2016-04-05 | 44,825 | — | $0 | 84,212 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-04-04 | 2016-04-05 | 22,418 | $29.18 | $654.2K | 29,931 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-04-04 | 2016-04-05 | 6,416 | $29.68 | $190.4K | 23,515 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-04-04 | 2016-04-05 | 788 | $30.00 | $23.6K | 22,727 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-04-04 | 2016-04-05 | 44,825 | $0.48 | $21.5K | 67,552 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-04-04 | 2016-04-05 | 15,203 | $28.17 | $428.3K | 52,349 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise deriv | 2016-04-01 | 2016-04-05 | 90,963 | — | $0 | 129,037 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-04-01 | 2016-04-05 | 40,506 | $25.69 | $1.04M | 73,184 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | M Exercise | 2016-04-01 | 2016-04-05 | 90,963 | $0.48 | $43.7K | 113,690 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-04-01 | 2016-04-05 | 38,080 | $26.67 | $1.02M | 35,104 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-04-01 | 2016-04-05 | 12,377 | $27.56 | $341.1K | 22,727 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2016-02-01 | 2016-02-03 | 176,500 | — | $0 | 176,500 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 22,727 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion | 2015-06-26 | 2015-06-29 | 22,727 | — | $0 | 22,727 | SEC↗ |